AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Frontline Announces $0.18 Dividend for Q2 2023.
ByAinvest
Friday, Jun 6, 2025 8:45 am ET1min read
Frontline (NYSE:FRO) has declared a quarterly dividend of $0.18 per share, with a forward yield of 3.97%. The dividend is payable on June 24 for shareholders of record on June 12 and ex-dividend on June 12.
Frontline (NYSE: FRO) has declared a quarterly dividend of $0.18 per share, with a forward yield of 3.97%. The dividend will be payable on June 24, 2025, to shareholders of record on June 12, 2025, and the ex-dividend date is June 12, 2025 [2].The dividend announcement comes amidst a period of market volatility and geopolitical shifts, as highlighted at the 2025 Sohn Investment Conference in Hong Kong. Hedge funds at the conference revealed diverse stock picks across sectors, including AI-driven mobility, healthcare, and defense, signaling their strategy to diversify investments [3].
Frontline's dividend yield is relatively attractive compared to other companies in the sector. For instance, Greif (GEF) has a quarterly dividend of $0.54 per share, while Stewart Information Services (STC) declared $0.50 per share for the second quarter of 2025. Buckle and Dollar General both have quarterly dividends of $0.35 and $0.59 per share, respectively [1].
The quarterly dividend announcement by Frontline aligns with its history of consistent dividend payments, which can be an attractive feature for income-focused investors. However, the forward yield of 3.97% is lower than the annual dividend yield of 19.15 NOK per share for Frontline, which is paid every three months [2].
Investors should consider the broader market conditions and Frontline's financial performance when evaluating the dividend. The company's ability to maintain or grow its dividend in the face of market volatility will be a key factor for income investors.
References:
[1] https://www.nasdaq.com/articles/daily-dividend-report-gef-gefbstcbkedgsig
[2] https://stockanalysis.com/quote/osl/FRO/dividend/
[3] https://www.econotimes.com/Hedge-Funds-Spotlight-Baidu-MedPlus-and-Hyundai-EC-at-Sohn-Hong-Kong-2025-1711963
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet